Your browser is unsupported

We recommend using the latest version of IE11, Edge, Chrome, Firefox or Safari.

In this section

Antonina Kuzmis

Graduate Program Coordinator, Biopharmaceutical Sciences

Contact Information

833 S. Wood Street (865)
Chicago, IL 60612

Phone: (312) 413-3708

Fax: (312) 996-0098

Intellectual Contributions

Journal Article

  • Khaja F, Jayawardena D, Kuzmis A, Önyüksel H. "Targeted Sterically Stabilized Phospholipid siRNA Nanomedicine for Hepatic and Renal Fibrosis.". Nanomaterials (Basel, Switzerland). 2016;6(1). doi:10.3390/nano6010008.
  • Vuković L, Madriaga A, Kuzmis A, Banerjee A, Tang A, Tao K, Shah N, Král P, Onyuksel H. "Solubilization of therapeutic agents in micellar nanomedicines.". Langmuir : the ACS journal of surfaces and colloids. 2013;29(51):15747-54. doi:10.1021/la403264w.
  • Gülçür E, Thaqi M, Khaja F, Kuzmis A, Onyuksel H. "Curcumin in VIP-targeted sterically stabilized phospholipid nanomicelles: a novel therapeutic approach for breast cancer and breast cancer stem cells.". Drug delivery and translational research. 2013;3(6). doi:10.1007/s13346-013-0167-6.
  • Sethi V, Rubinstein I, Kuzmis A, Kastrissios H, Artwohl J, Onyuksel H. "Novel, biocompatible, and disease modifying VIP nanomedicine for rheumatoid arthritis.". Molecular pharmaceutics. 2013;10(2):728-38. doi:10.1021/mp300539f.
  • Dagar A, Kuzmis A, Rubinstein I, Sekosan M, Onyuksel H. "VIP-targeted Cytotoxic Nanomedicine for Breast Cancer.". Drug delivery and translational research. 2012;2(6):454-62. doi:10.1007/s13346-012-0107-x.
  • Kuzmis A, Lim S, Desai E, Jeon E, Lee B, Rubinstein I, Onyuksel H. "Micellar nanomedicine of human neuropeptide Y.". Nanomedicine : nanotechnology, biology, and medicine. 2011;7(4):464-71. doi:10.1016/j.nano.2011.01.004.